Literature DB >> 33131347

Managing cognitive symptoms and fatigue in cholestatic liver disease.

Naw April Phaw1,2, Jessica Leighton1, Jessica Katharine Dyson1,2, David Ej Jones1,2,3.   

Abstract

Introduction: Patients with cholestatic diseases may develop fatigue and cognitive symptoms. The impact of symptom burden may be significant in some patients. To date, there are no effective pharmacological therapies to improve cognitive symptoms or fatigue in cholestasis and we are wholly reliant on supportive approaches. Area covered: This review provides an overview of cognitive symptoms and fatigue in the cholestatic liver disease primary biliary cholangitis (PBC), including pathophysiology and our approach to the management of these symptoms. Expert opinion: The impact of fatigue and cognitive symptoms on the perceived quality of life can be profound for patients with PBC. The pathophysiology of these symptoms is complex and poorly understood, making the development of therapeutic trials of symptom-directed therapies challenging. The current recommended management for fatigue and cognitive symptoms is mainly supportive.

Entities:  

Keywords:  Cognitive symptoms; central and peripheral fatigue; cholestasis; fatigue; primary biliary cholangitis

Mesh:

Year:  2020        PMID: 33131347     DOI: 10.1080/17474124.2021.1844565

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  1 in total

1.  Guidelines for the Management of Cholestatic Liver Diseases (2021).

Authors:  Lungen Lu
Journal:  J Clin Transl Hepatol       Date:  2022-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.